NCT02380313 Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone Status WITHDRAWN Phase PHASE1
NCT02379390 Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide Status TERMINATED Phase PHASE2
NCT02370550 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Status UNKNOWN Phase PHASE4
NCT02359162 Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage Status TERMINATED Phase PHASE3
NCT02356159 Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02348216 Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT02344017 Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02343536 A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma Status COMPLETED Phase PHASE1
NCT02337985 Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02334813 Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia Status COMPLETED Phase PHASE3
NCT02330952 Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD Status COMPLETED Phase PHASE4
NCT02298335 Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome:a Prospective Observational Study Status COMPLETED Phase NA
NCT02298283 Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD Status COMPLETED Phase PHASE2
NCT02294357 Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib Status TERMINATED Phase PHASE2
NCT02285062 Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE3
NCT02268149 Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects Status COMPLETED Phase PHASE1